Rucaparib Recruiting Phase 2 Trials for Fallopian Tube Cancer / Malignant Peritoneal Neoplasm / Cancer of the Ovary Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02873962A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib